Market open
Regencell Bioscience/$RGC
14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX
About Regencell Bioscience
Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.
Ticker
$RGC
Sector
Trading on
Industry
Pharmaceuticals
Headquarters
Causeway Bay, Hong Kong
Employees
12
Website
RGC Metrics
BasicAdvanced
$94M
Market cap
-
P/E ratio
-$0.33
EPS
-0.58
Beta
-
Dividend rate
Price and volume
Market cap
$94M
Beta
-0.58
52-week high
$32.44
52-week low
$3.03
Average daily volume
174K
Financial strength
Current ratio
41.916
Quick ratio
41.127
Long term debt to equity
0.316
Total debt to equity
1.043
Management effectiveness
Return on assets (TTM)
-28.11%
Return on equity (TTM)
-43.18%
Valuation
Price to book
11.48
Price to tangible book (TTM)
11.48
Price to free cash flow (TTM)
-23.544
Growth
Earnings per share change (TTM)
-26.73%
3-year earnings per share growth (CAGR)
34.90%
RGC Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Regencell Bioscience stock?
Regencell Bioscience (RGC) has a market cap of $94M as of November 08, 2024.
What is the P/E ratio for Regencell Bioscience stock?
The price to earnings (P/E) ratio for Regencell Bioscience (RGC) stock is 0 as of November 08, 2024.
Does Regencell Bioscience stock pay dividends?
No, Regencell Bioscience (RGC) stock does not pay dividends to its shareholders as of November 08, 2024.
When is the next Regencell Bioscience dividend payment date?
Regencell Bioscience (RGC) stock does not pay dividends to its shareholders.
What is the beta indicator for Regencell Bioscience?
Regencell Bioscience (RGC) has a beta rating of -0.58. This means that it has an inverse relation to market volatility.